Patent details

EP2590970 Title: CRYSTALLINE FORM OF RIVAROXABAN DIHYDRATE

  • Data
  • Documents

Basic Information

Publication number:
EP2590970
PCT Application Number:
PCT/EP/2011/061283
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117340505
PCT Publication Number:
WO/2012/004245
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORM OF RIVAROXABAN DIHYDRATE
French Title of Invention:
FORME CRISTALLINE DU RIVAROXABAN DIHYDRATÉ
German Title of Invention:
KRISTALLINE FORM VON RIVAROXABAN-DIHYDRAT
SPC Number:

Dates

Filing date:
05/07/2011
Grant date:
01/10/2014
EP Publication Date:
01/10/2014
PCT Publication Date:
12/01/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/05/2013
EP B1 Publication Date:
01/10/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/07/2015
Expiration date:
05/07/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/07/2011
 
 

Name:
Sandoz AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
ZIEGERT-KNEPPER Robert, E.
Address:
Austria (AT)

2

Name:
GRIESSER Ulrich
Address:
Austria (AT)

3

Name:
LUDESCHER Johannes
Address:
Austria (AT)

4

Name:
PICHLER Arthur
Address:
Austria (AT)

5

Name:
HADDOW Mairi
Address:
United Kingdom (GB)

6

Name:
STURM Hubert
Address:
Austria (AT)

Priority

Priority Number:
10168536
Priority Date:
06/07/2010
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07D 413/14;
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: